Jinye Bai
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
- Pharmacology top 10%
- Biological and pharmacological studies of plants
- Inflammatory mediators and NSAID effects
Papers in
-
- Inflammation biomarkers and pathways 2
- IL-33, ST2, and ILC Pathways 2
-
- Phytochemical compounds biological activities 2
- Natural product bioactivities and synthesis 2
- Co-authors
- Qi Hou (13 shared papers)Mingbao Lin (7 shared papers)Shaopeng Yuan (4 shared papers)Chun‐Suo Yao (6 shared papers)Gui-Fang Cheng (7 shared papers)Yuanyuan Zhuang (3 shared papers)Bao‐Song Cui (2 shared papers)Lingling Xuan (6 shared papers)
- Journals
- Journal of Asian Natural Products Research (3 papers)Frontiers in Pharmacology (3 papers)Journal of Medicinal Chemistry (2 papers)Acta Pharmacologica Sinica (2 papers)International Immunopharmacology (1 paper)
- Partner nations
- China
In The Last Decade
Jinye Bai
28 papers receiving 546 citations
Peers
Comparison fields: 5 of 86
- Geriatrics and Gerontology 31
- Pharmacology 97
- Immunology 102
- Pharmacology 35
- Complementary and alternative medicine 29
Countries citing papers authored by Jinye Bai
This map shows the geographic impact of Jinye Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinye Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinye Bai more than expected).
Fields of papers citing papers by Jinye Bai
This network shows the impact of papers produced by Jinye Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinye Bai. The network helps show where Jinye Bai may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinye Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 72 | |
| 2 | 2014 | 70 | |
| 3 | 2015 | 56 | |
| 4 | 2015 | 44 | |
| 5 | Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect. | 2004 | 39 |
| 6 | 2006 | 31 | |
| 7 | 2019 | 30 | |
| 8 | 2013 | 26 | |
| 9 | 2014 | 25 | |
| 10 | 2019 | 25 | |
| 11 | 2012 | 21 | |
| 12 | 2017 | 20 | |
| 13 | 2005 | 19 | |
| 14 | 2014 | 13 | |
| 15 | 2017 | 10 | |
| 16 | [Effects of dihydroxy-stilbene compound Vam3 on airway inflammation, expression of ICAM-1, activities of NF-kappaB and MMP-9 in asthmatic mice]. | 2010 | 9 |
| 17 | 2014 | 8 | |
| 18 | 2016 | 8 | |
| 19 | 2021 | 7 | |
| 20 | [Effects of Vam3 on sodium nitroprusside-induced apoptosis and SIRT1 and p53 expression in rat articular chondrocytes]. | 2014 | 4 |
About Jinye Bai
Jinye Bai is a scholar working on Immunology, Molecular Biology, Pharmacology, Physiology and Organic Chemistry, having authored 28 papers that have together received 552 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (4 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Inflammatory mediators and NSAID effects (2 papers), Inflammation biomarkers and pathways (2 papers), Phytochemical compounds biological activities (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Geriatrics and Gerontology (31 citations), Pharmacology (97 citations), Immunology (102 citations), Pharmacology (35 citations) and Complementary and alternative medicine (29 citations). Jinye Bai has collaborated with scholars based in China. Frequent co-authors include Qi Hou, Mingbao Lin, Shaopeng Yuan, Chun‐Suo Yao, Gui-Fang Cheng, Yuanyuan Zhuang, Bao‐Song Cui, Lingling Xuan, Qi Hou and Shimeng Zhang. Their work appears in journals such as Journal of Asian Natural Products Research, Frontiers in Pharmacology, Journal of Medicinal Chemistry, Acta Pharmacologica Sinica and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.